Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
86
datasets available to search
ShareScore release 0.9.0
Dataset results
86 results for “risankizumab”
Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)
ClinicalTrials.gov study NCT05685940. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT07039110. IPD Sharing: UNDECIDED. Countries: 8. Publications: 0.
Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan
ClinicalTrials.gov study NCT04818385. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Croh
ClinicalTrials.gov study NCT05995353. IPD Sharing: YES. Countries: 21. Publications: 0.
Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants
ClinicalTrials.gov study NCT05274100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants
ClinicalTrials.gov study NCT06571266. IPD Sharing: NO. Countries: 1. Publications: 0.
Risankizumab in Children With Crohn's Disease (RisaKids)
ClinicalTrials.gov study NCT06298188. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risankizumab for Fibrostenotic Crohn's Disease Treatment
ClinicalTrials.gov study NCT07177118. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
ClinicalTrials.gov study NCT06346288. IPD Sharing: YES. Countries: 2. Publications: 0.
Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT06764706. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
ClinicalTrials.gov study NCT04846959. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece
ClinicalTrials.gov study NCT06247319. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
ClinicalTrials.gov study NCT06063967. IPD Sharing: YES. Countries: 20. Publications: 0.
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
ClinicalTrials.gov study NCT06880744. IPD Sharing: YES. Countries: 31. Publications: 0.
A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03219437. IPD Sharing: YES. Countries: 1. Publications: 0.
Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
ClinicalTrials.gov study NCT06606808. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis
ClinicalTrials.gov study NCT04451720. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants
ClinicalTrials.gov study NCT07007091. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
ClinicalTrials.gov study NCT07071519. IPD Sharing: YES. Countries: 10. Publications: 0.
A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participants in China
ClinicalTrials.gov study NCT05268068. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.